Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma

Hellenic Society of Medical Oncology

Status: Completed

Conditions: Pancreatic Adenocarcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT03266757

N/A-NI-PANC-HeSMO-005490

Details and patient eligibility

About

Observational study of the Clinical Practice in patients with Borderline resectable or resectable or advanced pancreatic adenocarcinoma.

Enrollment: 200 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients Age 18 or older with histologically confirmed ductal pancreatic adenocarcinoma as a primary tumor
• Patients with ductal pancreatic adenocarcinoma (Borderline resectable or resectable or advanced)
• Patients that are alive and under treatment or follow up
• Signed informed consent (ICF)

Exclusion criteria

• Presence of other primary tumors
• Pancreatic adenocarcinoma due to metastasis from other primary tumor(s)
• Neuroendocrine or other pancreatic carcinoma other than ductal adenocarcinoma
• Patients who refuse to provide informed consent